Tricaine mesylate: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[WP:CHEMVALID|Chem/Drugbox validat... |
Open access status updates in citations with OAbot #oabot |
||
(45 intermediate revisions by 38 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{cs1 config|name-list-style=vanc}} |
|||
{{redirect-multi|1|MS-222|other uses|MS222 (disambiguation){{!}}MS222}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
<!--Clinical data-->| tradename = |
||
⚫ | |||
| tradename = |
|||
| |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
⚫ | |||
⚫ | |||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|||
⚫ | |||
| |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
||
| |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
||
⚫ | |||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
⚫ | |||
⚫ | |||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 971ZM8IPK1 |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 12878 |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C9H11NO2.CH4O3S/c1-2-12-9(11)7-4-3-5-8(10)6-7;1-5(2,3)4/h3-6H,2,10H2,1H3;1H3,(H,2,3,4) |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = FQZJYWMRQDKBQN-UHFFFAOYSA-N |
|||
<!-- |
<!--Chemical data-->| chemical_formula = |
||
| C = 10 |
|||
⚫ | |||
| H = 15 |
|||
⚫ | |||
| N = 1 |
|||
⚫ | |||
| O = 5 |
|||
⚫ | |||
| S = 1 |
|||
| excretion = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Chemical data--> |
|||
| chemical_formula = |
|||
| C=10 | H=15 | N=1 | O=5 | S=1 |
|||
| molecular_weight = 261.296 g/mol |
|||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
'''Tricaine mesylate''' ('''Tricaine methanesulfonate''', '''TMS''', '''MS-222'''), is white powder used for [[anesthesia]], sedation, or [[euthanasia]] of |
'''Tricaine mesylate''' ('''Tricaine methanesulfonate''', '''TMS''', '''MS-222, Syncaine, Tricaine-S,'''), is white powder used for [[anesthesia]], sedation, or [[euthanasia]] of fish. TMS is the only anesthetic licensed in the United States for fin fish that are intended for human consumption. |
||
The drug can have selective toxicity for [[poikilotherm]]s due to their lower rate of metabolism in the liver<ref>Wayson KA |
The drug can have selective toxicity for [[poikilotherm]]s due to their lower rate of metabolism in the liver.<ref name="pmid185356">{{cite journal | vauthors = Wayson KA, Downes H, Lynn RK, Gerber N | title = Studies on the comparative pharmacology and selective toxicity of tricaine methanesulfonate: metabolism as a basis of the selective toxicity in poikilotherms | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 198 | issue = 3 | pages = 695–708 | date = September 1976 | pmid = 185356 }}</ref> |
||
Tricaine is an anaesthetic that operates by preventing sodium ions to enter the cell and thus silencing [[action potentials]].<ref>{{Cite journal|url=https://link.springer.com/article/10.1007/s11160-010-9188-0|doi = 10.1007/s11160-010-9188-0|title = A review of tricaine methanesulfonate for anesthesia of fish|year = 2011| vauthors = Carter KM, Woodley CM, Brown RS |journal = Reviews in Fish Biology and Fisheries|volume = 21| issue=1 |pages = 51–59| bibcode=2011RFBF...21...51C |s2cid = 39693748|url-access = subscription}}</ref> This has the net effect of blocking signal exchange between the [[brain]] and extremities. |
|||
TMS is a [[muscle relaxant]] that operates by preventing [[action potential]]s. By blocking action potentials, no signals can be exchanged between the [[brain]] and the extremities. There will be no [[sensory input]] or [[muscle contraction]]s which would have been caused by action potential, which includes most muscles. |
|||
MSD Animal Health is one of the largest manufacturers of Tricaine in Norway and other European markets under the brand name Finquel.<ref>{{Cite web |date=2019-03-05 |title=MSD ANIMAL HEALTH ACQUIRES SCAN AQUA AS |url=https://fishfocus.co.uk/msd-animal-health-acquires-scan-aqua/ |access-date=2022-06-06 |website=Fish Focus |language=en-GB}}</ref> The largest manufacturer of Tricaine in North America is Syndel under the brand name Syncaine. Syncaine is manufactured in [[Ferndale, Washington]], in the United States.<ref>{{Cite web|url=https://syndel.com/product/tricaine-s-ms-222/|title=Tricaine-S (MS-222) Fish Anesthetic {{!}} Aqualife TMS Fish Sedative|website=Syndel|language=en|access-date=2019-12-12}}</ref>{{Better source needed|date=June 2021}} Syncaine is used for handling fish, [[amphibian]]s, and other cold-blooded animals during manual spawning, as well as during marking, measuring, photography, research, surgical operations, transport, and weighing of fish. |
|||
⚫ | |||
⚫ | |||
It is easily soluble in water (both fresh and salt) but it drastically decreases the [[pH]] of water, increasing the acidity, which may be toxic for fish. [[Baking soda]] or [[sodium bicarbonate]] is used to buffer the solution to a pH range of 6.5-7.5. Usually an equal amount of buffer is added to attain a neutral pH <ref>www.research.cornell.edu/CARE/documents/SOPs/CARE306.pdf</ref>. In salt/marine/sea water, the buffer use may not be necessary because sea water itself has buffering capacity. |
|||
It is easily soluble in water (both fresh and salt) but it drastically decreases the [[pH]] of water, increasing the acidity, which may be toxic for fish. [[Sodium bicarbonate]] can be used to buffer the solution to a pH range of 6.5-7.5. Usually an equal amount of buffer is added to attain a neutral pH.<ref>{{cite book | vauthors = Brown C, Pavek T | veditors = Bowser P | chapter = Fish and Amphibian Euthanasia | title = Animal Care and Use Procedure (ACUP) | url = http://www.research.cornell.edu/care/documents/ACUPs/ACUP306.pdf | archive-url = https://web.archive.org/web/20150613124936/http://www.research.cornell.edu/care/documents/ACUPs/ACUP306.pdf | archive-date = 13 June 2015 | publisher = Cornell University }}</ref> In salt/marine/sea water, the buffer use may not be necessary because sea water itself has buffering capacity {{Citation needed|date=June 2021}}. The solution of TMS needs to be prepared freshly each time because TMS is light-sensitive and might form toxic by-products upon exposure to light {{Citation needed|date=June 2021}}. Fish treated with Tricaine cannot be slaughtered for human consumption until a certain withdrawal period is reached, for example 21 days in the United States for Syncaine.<ref>{{Cite web |title=Approved Aquaculture Drugs FDA |website=[[Food and Drug Administration]] |date=26 July 2023 |url=https://www.fda.gov/animal-veterinary/aquaculture/approved-aquaculture-drugs }}</ref> |
|||
The solution of TMS needs to be prepared freshly each time because TMS is light-sensitive and might form toxic by-products upon exposure to light. |
|||
==References== |
== References == |
||
{{Reflist}} |
|||
<references/> |
|||
{{DEFAULTSORT:Tricaine Mesylate}} |
|||
[[Category:General anesthetics]] |
[[Category:General anesthetics]] |
||
[[Category: |
[[Category:Benzoate esters]] |
||
[[it:Tricaina metansolfonato]] |
|||
[[ta:டிரைகைன் மெத்தனோசல்பானேட்]] |